Financial Information Q2 2015
Financial Information Q2 2015
HALF-YEAR (JANUARY–JUNE, 2015) · Net sales for the period amounted to SEK 165.1 M (105.8), of which RayStation® accounted for SEK 106.6 M (50.9) · Profit after tax totaled SEK 22.4 M (5.9) and earnings per share were SEK 0.65 (0.17) · Operating profit amounted to SEK 31.0 M (8.4) · Cash flow was a negative SEK 2.3 M (neg: 11.3) · Order intake excluding service agreements amounted to SEK 158.3 M (101.6), of which RayStation® accounted for SEK 124.4 M (59.1) SECOND QUARTER (APRIL–JUNE, 2015) · Net sales for the period amounted to SEK 77.3 M (51.9), of which
Read originalMD Anderson Cancer Center recently closed a request for proposal (RFP) for the acquisition of new radiation therapy planning software to expand current approaches and investigate new technologies.On August 18, 2015, a purchase agreement was signed, finalizing an RFP put forward by The University of Texas MD Anderson Cancer Center, this spring, to assist in the selection and assessment of new treatment planning technologies. The conclusion and rationale for the selection of the RaySearch Laboratories treatment planning system (TPS) was that “the RayStation® system offers a new environment
Read original